Pliant Therapeutics Inc (PLRX) Price Prediction & ForecastPLRXPliant Therapeutics Inc

Alphio's PLRX stock price prediction model matches the current Pliant Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.10 (-0.57%). The 1-week path is $1.10 (-1.08%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Pliant Therapeutics Inc is not a strong buy right now due to its current price of $1.11, which is significantly below the analyst price target of $3. The company has a negative forward P/E ratio of 0, indicating that it is not generating profits at this time, and the RSI of 42.609 suggests it is nearing oversold territory. However, the recent insider buying activity and a strong cash position of $192.4 million, projected to fund operations into 2028, provide some support. The main risk is its declining net income, which has been negative for several quarters, with the latest reported at -$22.37 million for Q2 2026.

Pliant Therapeutics Inc (PLRX) last closed at $1.11, gaining +0.91%. These facts feed the 1-day and 1-week PLRX price prediction above.